Related Experiment Videos
Progesterone does not influence vascular function in postmenopausal women
Suzy Y Honisett1, Ben Pang, Lily Stojanovska
1Baker Medical Research Institute, Prahran, Melbourne, Australia.
Journal of Hypertension
|June 5, 2003
Summary
Progesterone alone does not negatively impact vascular function in postmenopausal women. This study found no adverse effects on blood pressure, arterial compliance, or other vascular markers when using progesterone without estrogen.
Area of Science:
- Reproductive endocrinology
- Cardiovascular health
- Menopause research
Background:
- Estrogen therapy is known to protect cardiovascular risk parameters.
- The effects of progesterone on vascular function in an estrogen-deprived state remain unclear.
Purpose of the Study:
- To investigate the impact of progesterone monotherapy on vascular function and hormone levels in postmenopausal women.
Main Methods:
- A randomized, double-blind, cross-over study involving 20 healthy postmenopausal women.
- Treatment involved 6 weeks of micronized progesterone (100 mg/daily) or placebo.
- Vascular function markers (blood pressure, flow-mediated dilation, arterial compliance, vascular reactivity) and hormone levels were measured.
Main Results:
- Progesterone treatment significantly increased progesterone levels and decreased follicle-stimulating hormone levels.
- No significant changes were observed in systemic arterial compliance, flow-mediated dilation, cutaneous vascular reactivity, blood pressure, or lipid profiles.
Conclusions:
- Progesterone, when administered without estrogen, does not adversely affect vascular function in postmenopausal women.
- This suggests a potentially safe profile for progesterone monotherapy regarding cardiovascular parameters in this population.